Literature DB >> 14229577

4-HYDROXYPYRAZOLO (3,4-D) PYRIMIDINE (HPP) IN THE TREATMENT OF GOUT: PRELIMINARY OBSERVATIONS.

A P HALL, V P HOLLOWAY, J T SCOTT.   

Abstract

Entities:  

Keywords:  BLOOD; COLCHICINE; DIET THERAPY; DRUG THERAPY; ENZYME INHIBITORS; GERIATRICS; GOUT; PROBENECID; PURINES; PYRAZOLES; PYRIMIDINES; TOXICOLOGIC REPORT; URIC ACID; URINE; XANTHINE OXIDASE; XANTHINES

Mesh：

Substances：

Year:  1964        PMID： 14229577      PMCID： PMC1030959          DOI： 10.1136/ard.23.6.439

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  XANTHINURIA AND HEMOCHROMATOSIS.

Authors:  J H AYVAZIAN
Journal:  N Engl J Med       Date:  1964-01-02       Impact factor: 91.245

2.  The old and new concepts of acute gouty arthritis.

Authors:  J E SEEGMILLER; R R HOWELL
Journal:  Arthritis Rheum       Date:  1962-12

3.  Nephrotic syndrome caused by probenecid.

Authors:  T F FERRIS; W S MORGAN; H LEVITIN
Journal:  N Engl J Med       Date:  1961-08-24       Impact factor: 91.245

4.  Gout and hyperuricaemia in rural and urban populations.

Authors:  A J POPERT; J V HEWITT
Journal:  Ann Rheum Dis       Date:  1962-06       Impact factor: 19.103
  4 in total
  14 in total

1.  TO-DAY'S DRUGS. DRUGS IN THE TREATMENT OF GOUT.

Authors:  M BEARE
Journal:  Br Med J       Date:  1965-01-16

2.  Allopurinol for gout.

Authors: 
Journal:  Br Med J       Date:  1966-08-06

Review 3.  Gout treatment: what is evidence-based and how do we determine and promote optimized clinical care?

Authors:  Ted R Mikuls; Kenneth G Saag
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

4.  Probenecid, nephrotic syndrome, and renal failure.

Authors:  J T Scott; P K O'Brien
Journal:  Ann Rheum Dis       Date:  1968-05       Impact factor: 19.103

5.  Long-term use of allopurinol in the treatment of gout.

Authors:  G D Kersley
Journal:  Ann Rheum Dis       Date:  1970-01       Impact factor: 19.103

6.  Allopurinol in the treatment of uraemic patients with gout.

Authors:  J D Wilson; H A Simmonds; J D North
Journal:  Ann Rheum Dis       Date:  1967-03       Impact factor: 19.103

7.  Treatment of gout by reduction of uric acid production.

Authors:  G D Kersley
Journal:  Ann Rheum Dis       Date:  1966-07       Impact factor: 19.103

8.  Uric acid production with particular reference to the role of xanthine oxidase and its inhibition.

Authors:  R W Watts
Journal:  Proc R Soc Med       Date:  1966-04

9.  Allopurinal and acute uric acid nephropathy.

Authors:  R W Watts; P J Watkins; J Q Matthias; D A Gibbs
Journal:  Br Med J       Date:  1966-01-22

10.  Kinetics of allopurinol after single intravenous and oral doses. Noninteraction with benzbromarone and hydrochlorothiazide.

Authors:  B Breithaupt; M Tittel
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.